Shanghai Ming Ju Biotechnology Co., Ltd.
17
3
6
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
5.9%
1 terminated/withdrawn out of 17 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL
Role: lead
JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases
Role: collaborator
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
Role: lead
CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
Role: lead
Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis
Role: collaborator
Relmacabtagene Autoleucel in Patients With LBCL
Role: lead
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus
Role: lead
Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma
Role: collaborator
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Role: lead
MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors
Role: collaborator
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma
Role: lead
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma
Role: lead
Phase I Study of JWCAR029 in Subjects With R/R CLL/SLL
Role: lead
CD19-targeted CAR T Cells （JWCAR029） for Primary Refractory Diffuse Large B Cell Lymphoma
Role: lead
Relmacabtagene Autoleucel in Hematologic Malignancies
Role: lead
CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus
Role: lead
CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia
Role: lead
All 17 trials loaded